• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombotic Microangiopathy After Kidney Pancreas Transplant Managed With Eculizumab and a Calcineurin Inhibitor-free Basiliximab/Belatacept Maintenance Regimen: Between a Rock and a Hard Place.

作者信息

Chen Jeanne M, Yaqub Muhammad S, Jan Muhammad Y, Sharfuddin Asif A, Powelson John A, Lutz Andrew J, Hata Jessica L, Fridell Jonathan A

机构信息

Department of Pharmacy, IU Health, Indianapolis, IN.

Department of Surgery, Indiana University School of Medicine, Indianapolis, IN.

出版信息

Transplant Direct. 2025 Jun 12;11(7):e1825. doi: 10.1097/TXD.0000000000001825. eCollection 2025 Jul.

DOI:10.1097/TXD.0000000000001825
PMID:40519672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12165658/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/12165658/e15a13b44d06/txd-11-e1825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/12165658/789860a0e0ea/txd-11-e1825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/12165658/b52e8ee658aa/txd-11-e1825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/12165658/e15a13b44d06/txd-11-e1825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/12165658/789860a0e0ea/txd-11-e1825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/12165658/b52e8ee658aa/txd-11-e1825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df2/12165658/e15a13b44d06/txd-11-e1825-g003.jpg

相似文献

1
Thrombotic Microangiopathy After Kidney Pancreas Transplant Managed With Eculizumab and a Calcineurin Inhibitor-free Basiliximab/Belatacept Maintenance Regimen: Between a Rock and a Hard Place.肾胰联合移植后血栓性微血管病采用依库珠单抗及无钙调神经磷酸酶抑制剂的巴利昔单抗/贝拉西普维持方案治疗：进退两难。
Transplant Direct. 2025 Jun 12;11(7):e1825. doi: 10.1097/TXD.0000000000001825. eCollection 2025 Jul.
2
Use of Eculizumab in Transplant-Associated Thrombotic Microangiopathy in a Patient With Polycystic Kidney Disease Immediately Post-Kidney Transplant: A Case Report.依库珠单抗在多囊肾病患者肾移植术后即刻发生的移植相关血栓性微血管病中的应用：一例报告
Kidney Med. 2020 Aug 5;2(5):652-656. doi: 10.1016/j.xkme.2020.06.007. eCollection 2020 Sep-Oct.
3
Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report.巴利昔单抗用于肺移植术后早期围手术期移植相关血栓性微血管病：一例报告
Surg Case Rep. 2022 Sep 29;8(1):187. doi: 10.1186/s40792-022-01539-x.
4
Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature.儿童肾移植伴移植相关血栓性微血管病极早期转换为贝拉西普的安全性和有效性：病例研究及文献综述
Clin Pract. 2024 May 16;14(3):882-891. doi: 10.3390/clinpract14030069.
5
De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.接受依库珠单抗治疗的胰肾联合移植术后新发血栓性微血管病
Nephrology (Carlton). 2017 Feb;22 Suppl 1:23-27. doi: 10.1111/nep.12936.
6
Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.贝拉西普和依库珠单抗治疗肾移植后钙调神经磷酸酶抑制剂诱导的血栓性微血管病：病例报告
Transplant Proc. 2016 Nov;48(9):3106-3108. doi: 10.1016/j.transproceed.2016.04.005.
7
Belatacept for kidney transplant recipients.用于肾移植受者的贝拉西普。
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2.
8
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.钙调磷酸酶抑制剂方案转换为贝利尤单抗作为挽救治疗的肾移植受者 3 年结局。
Transpl Int. 2022 Apr 13;35:10228. doi: 10.3389/ti.2022.10228. eCollection 2022.
9
Eculizumab in Transplant-Associated Thrombotic Microangiopathy.依库珠单抗治疗移植相关血栓性微血管病
Clin Appl Thromb Hemost. 2017 Mar;23(2):175-180. doi: 10.1177/1076029615599439. Epub 2016 Jul 10.
10
Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy.在三名新发药物性血栓性微血管病的肾移植患者中使用贝拉西普作为替代免疫抑制剂。
Case Rep Med. 2013;2013:260254. doi: 10.1155/2013/260254. Epub 2013 Oct 1.

本文引用的文献

1
Safety and Efficacy of Belatacept in Pancreas Transplantation: A Case Series.贝拉西普在胰腺移植中的安全性和有效性：病例系列
Clin Transplant. 2025 Mar;39(3):e70131. doi: 10.1111/ctr.70131.
2
Post-transplant Thrombotic Microangiopathy.移植后血栓性微血管病
J Am Soc Nephrol. 2025 May 1;36(5):940-951. doi: 10.1681/ASN.0000000645. Epub 2025 Jan 31.
3
The Use of Long-Term Monthly Basiliximab Infusions as Rescue Maintenance Immunosuppression in Pancreas Transplant Recipients.长期每月使用巴利昔单抗输注作为胰腺移植受者的挽救维持免疫抑制治疗
Clin Transplant. 2024 Dec;38(12):e70050. doi: 10.1111/ctr.70050.
4
Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series.贝拉西普在胰腺移植中的应用：来自队列研究系列的有前景的见解。
Transpl Int. 2024 Apr 16;37:12778. doi: 10.3389/ti.2024.12778. eCollection 2024.
5
Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas Transplantation.肾胰联合移植术后早期的贝拉西普挽救治疗
Transpl Int. 2024 Apr 11;37:12628. doi: 10.3389/ti.2024.12628. eCollection 2024.
6
Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra.肾移植后的血栓性微血管病：病因和发病机制范围的扩展
World J Transplant. 2024 Mar 18;14(1):90277. doi: 10.5500/wjt.v14.i1.90277.
7
TMA in Kidney Transplantation.肾移植中的组织微阵列分析
Transplantation. 2023 Nov 1;107(11):2329-2340. doi: 10.1097/TP.0000000000004585. Epub 2023 Oct 21.
8
Pancreas transplantation would be easy if the recipients were not diabetic: A practical guide to post-operative management of diabetic complications in pancreas transplant recipients.如果受者没有糖尿病，胰腺移植将会很容易：胰腺移植受者术后糖尿病并发症处理实用指南。
Clin Transplant. 2021 May;35(5):e14270. doi: 10.1111/ctr.14270. Epub 2021 Mar 11.
9
Contrast-Enhanced Ultrasound Versus Doppler Ultrasound for Detection of Early Vascular Complications of Pancreas Grafts.对比增强超声与多普勒超声在胰腺移植物早期血管并发症检测中的比较
AJR Am J Roentgenol. 2020 Nov;215(5):1093-1097. doi: 10.2214/AJR.20.22858. Epub 2020 Sep 22.
10
Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trial.联合胰腺和肾移植后钙调磷酸酶抑制剂停药的挑战：一项前瞻性、随机临床试验的结果。
Am J Transplant. 2020 Jun;20(6):1668-1678. doi: 10.1111/ajt.15817. Epub 2020 Mar 8.